Inflamación y Daño Vascular en la Enfermedad Renal Crónica, Diálisis y Trasplante Renal. Fisiopatología renal

Galan, I; Goicoechea, M; Quiroga, B; Macias, N; Santos, A; de Vinuesa, MSG; Verdalles, U; Cedeno, S; Verde, E; de Jose, AP; Garcia, A; Luno, J.

Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass

NEFROLOGIA. 2018; 38(1): 73-78 Nº de citas: 14 [doi:10.1016/j.nefro.2017.04.006]

Aboulmagd, S; Esteban-Fernandez, D; Moreno-Gordaliza, E; Neumann, B; El-Khatib, AH; Lazaro, A; Tejedor, A; Gomez-Gomez, MM; Linscheid, MW.

Dual Internal Standards with Metals and Molecules for MALDI Imaging of Kidney Lipids

ANAL CHEM. 2017; 89(23): 12727-12734 Nº de citas: 4 [doi:10.1021/acs.analchem.7602819]

Sanchez, MAG; Urkola, XK; Santiago, EB; Garcia, PM; Moreno, EV; Alvarez, MCF; Cobo, RT; Pulido, JMP; Gonzalez, AD; Regueiro, DS; Morales, JR; Rodriguez-Alvarez, RJ; Miranda, IA; Loyarte, JAI; Grp GAMES.

Aetiology of renal failure in patients with infective endocarditis. The role of antibiotics

MEDICINA CLINICA. 2017; 149(8): 331-338 Nº de citas: 6 [doi:10.1016/j.medcli.2017.03.009]

Sanchez-Nino, MD; Zheng-Lin, B; Valino-Rivas, L; Sanz, AB; Ramos, AM; Luno, J; Goicoechea, M; Ortiz, A.

Lesinurad: what the nephrologist should know

Clinical Kidney Journal. 2017; 10(5): 679-687 Nº de citas: 33 [doi:10.1093/ckj/sfx036]

Goicoechea, M; Sanchez-Nino, MD; Ortiz, A; de Vinuesa, SG; Quiroga, B; Bernis, C; Morales, E; Fernandez-Juarez, G; de Sequera, P; Verdalles, U; Verde, E; Luno, J.

Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients

PROSTAG LEUKOTR ESS. 2017; 125: 8-13 Nº de citas: 15 [doi:10.1016/j.plefa.2017.08.009]

Humanes, B; Camano, S; Lara, JM; Sabbisetti, V; Gonzalez-Nicolas, MA; Bonventre, JV; Tejedor, A; Lazaro, A.

Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection

NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017; 32(10): 1645-1655 Nº de citas: 63 [doi:10.1093/ndt/gfx005]

Ramos-Martinez, A; Roque, F; Farinas, MC; Munoz, P; Verde, E; Cuerpo, GP; de Alarcon, A; Lepe, JA; Miro, JM; Plata, A; Goenaga, MA; Garcia-Rosado, D; Martinez-Monzonis, A; de la Torre, J; Garcia-Pavia, P.

Prognostic factors of infective endocarditis in patients on hemodialysis: A case series from a National Multicenter Registry

INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017; 241: 295-301 Nº de citas: 14 [doi:10.1016/j.ijcard.2017.04.086]

Macias, N; Vega, A; Abad, S; Santos, A; Cedeno, S; Linares, T; Garcia-Prieto, AM; Aragoncillo, I; Yuste, C; Lopez-Gomez, JM.

Is High-Volume Online Hemodiafiltration Associated With Malnutrition?

THERAPEUTIC APHERESIS AND DIALYSIS. 2017; 21(4): 361-369 Nº de citas: 13 [doi:10.1111/1744-9987.12602]

Aragoncillo, I; Abad, S; Caldes, S; Amezquita, Y; Vega, A; Cirugeda, A; Moratilla, C; Ibeas, J; Roca-Tey, R; Fernandez, C; Macias, N; Quiroga, B; Blanco, A; Villaverde, M; Ruiz, C; Martin, B; Ruiz, AM; Ampuero, J; de Alvaro, F; Lopez-Gomez, JM.

Adding access blood flow surveillance reduces thrombosis and improves arteriovenous fistula patency: a randomized controlled trial

JOURNAL OF VASCULAR ACCESS. 2017; 18(4): 352-358 Nº de citas: 50 [doi:10.5301/jva.5000700]

Luno, J; Varas, J; Ramos, R; Merello, I; Aljama, P; MartinMalo, A; Pascual, J; Praga, M; ORD Grp.

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study

Kidney International Reports. 2017; 2(4): 665-675 Nº de citas: 6 [doi:10.1016/j.ekir.2017.03.001]

Carrasco-Anton, N; Lopez-Medrano, F; Fernandez-Ruiz, M; Carrillo, E; Moreno, J; Garcia-Reyne, A; Perez-Ayala, A; Rodriguez-Ferrero, ML; Lumbreras, C; San-Juan, R; Alvar, J; Aguado, JM.

Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain

EMERGING INFECTIOUS DISEASES. 2017; 23(7): 1155-1159 Nº de citas: 14 [doi:10.3201/eid2307.151251]

Mora, SC; Goicoechea, M; Torres, E; Verdalles, U; de Jose, AP; Verde, E; de Vinuesa, SG; Luno, J.

Cardiovascular risk prediction in chronic kidney disease patients

NEFROLOGIA. 2017; 37(3): 293-300 Nº de citas: 17 [doi:10.1016/j.nefro.2016.10.002]

Vega, A; Abad, S; Macias, N; Aragoncillo, I; Santos, A; Galan, I; Cedeno, S; Lopez-Gomez, JM.

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease

Clinical Kidney Journal. 2017; 10(2): 170-175 Nº de citas: 13 [doi:10.1093/ckj/sfw126]

Abad, S; Vega, A; Rincon, D; Hernandez, E; Merida, E; Macias, N; Munoz, R; Milla, M; Luno, J; Lopez-Gomez, JM.

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients

NEFROLOGIA. 2017; 37(2): 158-163 Nº de citas: 10 [doi:10.1016/j.nefro.2016.10.003]

Moreno-Gordaliza, E; Esteban-Fernandez, D; Lazaro, A; Humanes, B; Aboulmagd, S; Tejedor, A; Linscheid, MW; Gomez-Gomez, MM.

MALDI-LTQ-Orbitrap mass spectrometry imaging for lipidomic analysis in kidney under cisplatin chemotherapy

TALANTA. 2017; 164: 16-26 Nº de citas: 45 [doi:10.1016/j.talanta.2016.11.026]

Macias, N; Santos Garcia, A; Vega Martinez, A; Abad Estebanez, S; Goicoechea Diezhandino, M; Lopez Gomez, JM.

Importance of Body Water in the Efficacy of Convective Solute Transport in Online Hemodiafiltration

THERAPEUTIC APHERESIS AND DIALYSIS. 2017; 21(1): 88-95 Nº de citas: 5 [doi:10.1111/1744-9987.12486]

Abad, S; Vega, A; Hernandez, E; Merida, E; de Sequera, P; Albalate, M; Macias, N; Milla, M; Lopez-Gomez, JM.

Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4

AMERICAN JOURNAL OF NEPHROLOGY. 2017; 45(3): 267-272 Nº de citas: 17 [doi:10.1159/000454819]

Boada, M; Anaya, F; Ortiz, P; Olazaran, J; Shua-Haim, JR; Obisesan, TO; Hernandez, I; Munoz, J; Buendia, M; Alegret, M; Lafuente, A; Tarraga, L; Nunez, L; Torres, M; Grifols, JR; Ferrer, I; Lopez, OL; Paez, A.

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-beta Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial

JOURNAL OF ALZHEIMERS DISEASE. 2017; 56(1): 129-143 Nº de citas: 88 [doi:10.3233/JAD-160565]